Free Trial

Baird Financial Group Inc. Purchases 38,955 Shares of Select Medical Holdings Corporation $SEM

Select Medical logo with Medical background

Key Points

  • Baird Financial Group Inc. increased its stake in Select Medical Holdings Corporation by 13.0%, acquiring an additional 38,955 shares, bringing its total to 339,598 shares worth approximately $5.67 million.
  • Select Medical reported earnings per share of $0.32 for the latest quarter, exceeding analyst expectations of $0.28, and showed a 4.5% revenue growth year-over-year.
  • The company has recently announced a quarterly dividend of $0.0625 per share, equating to an annualized dividend of $0.25, with a yield of 1.9%.
  • MarketBeat previews the top five stocks to own by October 1st.

Baird Financial Group Inc. grew its stake in Select Medical Holdings Corporation (NYSE:SEM - Free Report) by 13.0% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 339,598 shares of the health services provider's stock after acquiring an additional 38,955 shares during the quarter. Baird Financial Group Inc. owned 0.26% of Select Medical worth $5,671,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Price T Rowe Associates Inc. MD lifted its position in Select Medical by 1.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 17,755,298 shares of the health services provider's stock valued at $296,515,000 after acquiring an additional 270,488 shares in the last quarter. Vanguard Group Inc. raised its stake in shares of Select Medical by 4.7% in the first quarter. Vanguard Group Inc. now owns 13,316,069 shares of the health services provider's stock worth $222,378,000 after purchasing an additional 603,079 shares during the last quarter. Principal Financial Group Inc. lifted its holdings in shares of Select Medical by 3.1% during the first quarter. Principal Financial Group Inc. now owns 2,476,816 shares of the health services provider's stock valued at $41,363,000 after purchasing an additional 73,308 shares in the last quarter. Northern Trust Corp boosted its position in shares of Select Medical by 12.9% during the fourth quarter. Northern Trust Corp now owns 1,352,046 shares of the health services provider's stock valued at $25,486,000 after buying an additional 153,992 shares during the last quarter. Finally, Bank of America Corp DE increased its holdings in Select Medical by 46.7% in the 4th quarter. Bank of America Corp DE now owns 1,192,578 shares of the health services provider's stock worth $22,480,000 after buying an additional 379,598 shares in the last quarter. 89.48% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on SEM. Bank of America lowered their price target on Select Medical from $18.00 to $15.00 and set a "buy" rating on the stock in a report on Wednesday. UBS Group reissued a "neutral" rating and issued a $14.00 target price (down previously from $15.00) on shares of Select Medical in a report on Monday, August 4th. Four analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $19.20.

Check Out Our Latest Stock Report on Select Medical

Select Medical Stock Performance

Select Medical stock traded down $0.47 during trading on Wednesday, reaching $12.46. The company had a trading volume of 775,758 shares, compared to its average volume of 840,060. The firm has a market capitalization of $1.54 billion, a price-to-earnings ratio of 11.75, a price-to-earnings-growth ratio of 0.53 and a beta of 1.25. The company has a current ratio of 1.15, a quick ratio of 1.15 and a debt-to-equity ratio of 0.92. The firm's 50-day simple moving average is $13.51 and its 200 day simple moving average is $15.21. Select Medical Holdings Corporation has a 52 week low of $11.65 and a 52 week high of $40.98.

Select Medical (NYSE:SEM - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The health services provider reported $0.32 EPS for the quarter, topping analysts' consensus estimates of $0.28 by $0.04. Select Medical had a return on equity of 8.87% and a net margin of 2.37%.The business had revenue of $1.34 billion during the quarter, compared to analysts' expectations of $1.35 billion. During the same quarter in the prior year, the business posted $0.60 earnings per share. The business's quarterly revenue was up 4.5% on a year-over-year basis. Select Medical has set its FY 2025 guidance at 1.090-1.19 EPS. Sell-side analysts forecast that Select Medical Holdings Corporation will post 1.17 earnings per share for the current fiscal year.

Select Medical Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, August 28th. Shareholders of record on Wednesday, August 13th were paid a dividend of $0.0625 per share. The ex-dividend date was Wednesday, August 13th. This represents a $0.25 dividend on an annualized basis and a yield of 2.0%. Select Medical's dividend payout ratio (DPR) is presently 23.58%.

Select Medical Company Profile

(Free Report)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

Featured Stories

Institutional Ownership by Quarter for Select Medical (NYSE:SEM)

Should You Invest $1,000 in Select Medical Right Now?

Before you consider Select Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.

While Select Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.